These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4980639)

  • 1. [On the problem of the inactivation of antibacterial drugs and drug resistance of disease agents].
    Rudoĭ NM; Lubenson AS
    Biull Eksp Biol Med; 1969 Feb; 67(2):43-5. PubMed ID: 4980639
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the inactivation of tubazid in the complex therapy of patients with pulmonary tuberculosis].
    Kartseva TM
    Probl Tuberk; 1970; 48(4):36-9. PubMed ID: 4990498
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 5. What is drug resistance?
    Mitchison DA
    Tubercle; 1969 Mar; 50():Suppl:44-7. PubMed ID: 4990182
    [No Abstract]   [Full Text] [Related]  

  • 6. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo].
    Belogurova VP; Gorislavets II; Ivanitskaia NN
    Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibacterial effect of Soliutizon].
    Pershin GN; Makeeva OO
    Probl Tuberk; 1966; 44(7):63-7. PubMed ID: 4969291
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dynamics of drug resistance and restoration of sensitivity of Mycobacterium tuberculosis isolated from patients].
    Belogurova VP; Navrotskiĭ VV
    Antibiotiki; 1970 May; 15(5):434-7. PubMed ID: 4988018
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation of lipid fractions, toxicity and virulence of M. tuberculosis isolated from patients treated with antibacterial preparations].
    Nemsadze MN
    Probl Tuberk; 1971; 49(11):66-9. PubMed ID: 5004859
    [No Abstract]   [Full Text] [Related]  

  • 11. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness, during the 1st year, of 3 treatment durations].
    Krebs A
    Bull Int Union Tuberc; 1974; 49(1):327-32. PubMed ID: 4219731
    [No Abstract]   [Full Text] [Related]  

  • 13. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance of Mycobacterium tuberculosis, the extent of isoniazid inactivation and blood bacteriostatic activity in chemotherapy of pulmonary tuberculosis].
    Tipp ZI
    Probl Tuberk; 1969; 47(8):76-9. PubMed ID: 4987468
    [No Abstract]   [Full Text] [Related]  

  • 15. Recall of isoniazid used for antimicrobial susceptibility testing for tuberculosis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(34):780-2. PubMed ID: 10987246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of acridine compounds on stopping the development of drug resistance in Mycobacterium tuberculosis (an experimental study)].
    Efremova IIa; Il'ina TB; Vishnevskiĭ BI; Vavilin GI
    Probl Tuberk; 1977 Sep; (9):61-4. PubMed ID: 411125
    [No Abstract]   [Full Text] [Related]  

  • 18. [Incidence of resistant mutants of Mycobacterium tuberculosis (MT) strains from different areas of Rumania. Bacteriological study--epidemiological aspects].
    Anastasatu C; Băicoianu S; Teodorescu A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):212-22. PubMed ID: 4998673
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inactivation of isonicotinic acid hydrazides in the organism of patients and drug resistance of Mycobacterium tuberculosis].
    Vil'derman AM; Finn ER; Evgrafova ZA
    Probl Tuberk; 1965; 43(8):72-5. PubMed ID: 5869069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.